BR0115451A - Suplemento a ser administrado por via enteral para a alimentação parenteral ou alimentação enteral/oral parcial em doentes crìticos, doentes crÈnicos e com nutrição deficiente - Google Patents

Suplemento a ser administrado por via enteral para a alimentação parenteral ou alimentação enteral/oral parcial em doentes crìticos, doentes crÈnicos e com nutrição deficiente

Info

Publication number
BR0115451A
BR0115451A BR0115451-6A BR0115451A BR0115451A BR 0115451 A BR0115451 A BR 0115451A BR 0115451 A BR0115451 A BR 0115451A BR 0115451 A BR0115451 A BR 0115451A
Authority
BR
Brazil
Prior art keywords
supplement
ill
patients
enteral
administered enterally
Prior art date
Application number
BR0115451-6A
Other languages
English (en)
Other versions
BRPI0115451B1 (pt
Inventor
Barbara Kessler
Angelika Riedel
Ulrich Suchner
Original Assignee
Fresenius Kabi De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi De Gmbh filed Critical Fresenius Kabi De Gmbh
Publication of BR0115451A publication Critical patent/BR0115451A/pt
Publication of BRPI0115451B1 publication Critical patent/BRPI0115451B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"SUPLEMENTO A SER ADMINISTRADO POR VIA ENTERAL PARA A ALIMENTAçãO PARENTERAL OU ALIMENTAçãO ENTERAL/ORAL PARCIAL EM DOENTES CRìTICOS, DOENTES CRÈNICOS E COM NUTRIçãO DEFICIENTE". Suplemento a ser administrado por via enteral para a alimentação parenteral ou na alimentação enteral/oral parcial em doentes críticos, doentes crónicos e pacientes com alimentação deficiente. é descrito um suplemento a ser administrado por via enteral para a obtenção ou reconstituição da barreira intestinal do intestino de doentes críticos ou crónicos bem como pacientes com alimentação deficiente. Este contém como solução, em cada caso com relação a uma dose diária, a) glutamina e/ou precursores da glutamina em uma quantidade na faixa de 15 até 70 g, b) pelo menos dois representantes do grupo das substâncias que atuam como antioxidantes e c) ácidos graxos em cadeia curta e/ou precursores de ácidos graxos em cadeia curta em uma quantidade de 0,5 até 10 g.
BRPI0115451A 2000-11-17 2001-11-14 suplemento a ser administrado por via enteral para a alimentação parenteral ou alimentação enteral/oral parcial em doentes críticos, doentes crônicos e com má nutrição, bem como aplicação dos componentes do mesmo BRPI0115451B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10057290A DE10057290B4 (de) 2000-11-17 2000-11-17 Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
PCT/EP2001/013163 WO2002039978A1 (de) 2000-11-17 2001-11-14 Enteral zu verabreichendes supplement zur parenteralen ernährung oder partiellen enteralen/oralen ernährung bei kritisch kranken, chronisch kranken und mangelernährten

Publications (2)

Publication Number Publication Date
BR0115451A true BR0115451A (pt) 2004-01-06
BRPI0115451B1 BRPI0115451B1 (pt) 2016-07-19

Family

ID=7663817

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0115451A BRPI0115451B1 (pt) 2000-11-17 2001-11-14 suplemento a ser administrado por via enteral para a alimentação parenteral ou alimentação enteral/oral parcial em doentes críticos, doentes crônicos e com má nutrição, bem como aplicação dos componentes do mesmo

Country Status (28)

Country Link
US (1) US7947303B2 (pt)
EP (1) EP1337236B1 (pt)
JP (1) JP2004513912A (pt)
KR (2) KR20080069280A (pt)
CN (1) CN1477950A (pt)
AT (1) ATE272390T1 (pt)
AU (2) AU2002224848B2 (pt)
BR (1) BRPI0115451B1 (pt)
CA (1) CA2429270C (pt)
CZ (1) CZ300129B6 (pt)
DE (2) DE10057290B4 (pt)
DK (1) DK1337236T3 (pt)
EE (1) EE05209B1 (pt)
ES (1) ES2223015T3 (pt)
HR (1) HRP20030395B1 (pt)
HU (1) HU228351B1 (pt)
IL (2) IL155840A0 (pt)
IS (1) IS2377B (pt)
MX (1) MXPA03004348A (pt)
NO (1) NO333003B1 (pt)
NZ (1) NZ525812A (pt)
PL (1) PL202031B1 (pt)
PT (1) PT1337236E (pt)
RU (1) RU2295952C2 (pt)
SI (1) SI1337236T1 (pt)
SK (1) SK286199B6 (pt)
WO (1) WO2002039978A1 (pt)
ZA (1) ZA200303722B (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254584A1 (de) * 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
WO2005023274A1 (en) * 2003-09-05 2005-03-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
US20070225203A1 (en) * 2003-09-19 2007-09-27 N.V. Nutricia Method and Composition for Preventing Multiple Organ Dysfunction Syndrome
DE10349585A1 (de) * 2003-10-24 2005-06-16 Biosyn Arzneimittel Gmbh Spurenelementzusammensetzung für die Ernährung
DE202004015931U1 (de) * 2004-10-13 2005-01-05 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Omega-3-Fettsäuren und Omega-6-Fettsäuren enthaltende Zusammensetzung
US20050148669A1 (en) * 2004-10-21 2005-07-07 Daniel Amato Amino acid esters as nutrient supplements and methods of use
RU2433819C2 (ru) * 2004-11-09 2011-11-20 Хилл'С Пет Ньютришн, Инк. Применение антиоксидантов для модуляции генов
CN101084003A (zh) * 2004-12-21 2007-12-05 重症救护联络公司 治疗性营养组合物或联合药物及其使用方法
AU2006240560B2 (en) 2005-04-27 2011-10-27 N.V. Nutricia Nutrition with lipids and non-digestible saccharides
EP1719543A1 (en) * 2005-05-04 2006-11-08 Asan Labs., Ltd. Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress
US20090104705A1 (en) * 2005-05-23 2009-04-23 Jan Frederik Stevens Ascorbic acid conjugates
JP2009506012A (ja) 2005-08-26 2009-02-12 ネステク ソシエテ アノニム 肥満患者の栄養素
DE102005046237A1 (de) * 2005-09-28 2007-04-05 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen
US20090312427A1 (en) * 2005-11-15 2009-12-17 Entress Ab Medicament for Use in Connection With Cartilage Impairment
EP1971230A2 (en) * 2006-01-09 2008-09-24 Nestec S.A. Treatment of stressed patients
US20100215631A1 (en) * 2006-06-14 2010-08-26 Anita Hartog Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
KR100774816B1 (ko) * 2006-11-21 2007-11-07 동부일렉트로닉스 주식회사 반도체 소자의 ｍｉｍ 커패시터 제조 방법 및 구조
BRPI0816993A2 (pt) * 2007-09-17 2014-10-07 Nutricia Nv Uso de uma composição, e, composição nutricional
EP2205235A4 (en) * 2007-10-14 2010-11-17 Univ Florida PREPARATION TO IMPROVE GASTROINTESTINAL FUNCTION
IT1396935B1 (it) * 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
US20130210715A1 (en) * 2010-04-26 2013-08-15 Nestec S.A. Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition
US20140030241A1 (en) * 2011-03-31 2014-01-30 Nestec S.A. Nutritional compositions for increasing arginine levels and methods of using same
KR20180100455A (ko) * 2011-04-13 2018-09-10 아지노모토 가부시키가이샤 영양 조성물
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
US9849144B2 (en) 2013-09-16 2017-12-26 Healios Oncology Nutrition, LLC Glutamine and trehalose compositions
BR112017026185A2 (pt) 2015-06-10 2018-08-14 Ajinomoto Kk agente e método para melhorar um distúrbio gastrointestinal induzido por exercício.
ES2638195B1 (es) * 2016-04-18 2018-08-02 Bioiberica, S.A. Composiciones para la piel
CA3062798A1 (en) 2017-05-09 2018-11-15 Baxter International Inc. Parenteral nutrition diagnostic system, apparatus, and method
CN108208177A (zh) * 2017-11-28 2018-06-29 上海交通大学医学院附属新华医院 含丁酸类化合物的组合物及其应用
PL423673A1 (pl) * 2017-12-01 2019-06-03 Lewandowska Agata Kompozycja do podawania doustnego, zastosowanie kompozycji w zapobieganiu i leczeniu mucositis oraz sposób leczenia mucositis
WO2021191469A1 (en) * 2020-03-27 2021-09-30 Basf Se Composition for the treatment of gastro-intestinal dysfunction and/or associated morbidities thereto
US11666548B2 (en) 2020-06-05 2023-06-06 Baxter International Inc. Parenteral nutrition formulation
US20220160669A1 (en) 2020-11-24 2022-05-26 Baxter International Inc. Parenteral nutrition formulation
DE202021102589U1 (de) 2020-12-15 2021-05-28 Marco Lautenschläger Verzehrfertiges, abgefülltes Getränk auf Basis eines natürlichen Mineralwassers
WO2023205635A1 (en) * 2022-04-19 2023-10-26 Vanderbilt University Compositions and methods of treatment for congenital diarrheal disorder
WO2023215458A1 (en) * 2022-05-06 2023-11-09 Ageless Sciences, Inc. Compositions and methods for slowing down aging and extending lifespan
CN116920075B (zh) * 2023-09-15 2024-01-02 潍坊市人民医院(潍坊市公共卫生临床中心) 一种肠内营养液及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3698912A (en) * 1969-07-01 1972-10-17 Morton Norwich Products Inc Process for making nutrient composition
DE3135849A1 (de) * 1981-09-10 1983-03-17 Dr. Schumacher GmbH & Co KG, 4600 Dortmund Beschichtungsstoff fuer korrosionsschutzzwecke
US4446389A (en) * 1982-03-15 1984-05-01 Ampex Corporation Quadrature tach decoder circuit
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
IL94549A (en) * 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
JP2524551B2 (ja) * 1992-02-28 1996-08-14 雪印乳業株式会社 グルタミン含量の高いペプチド組成物、その製造方法及び経腸栄養剤
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
ES2173109T3 (es) * 1992-12-23 2002-10-16 Abbott Lab Alimentos de unso medico destinados parael sostenimiento nutricional de recien nacidos/de bebes que padecen enfermedades metabolicas.
JP4059532B2 (ja) * 1994-08-15 2008-03-12 森永乳業株式会社 腸内細菌の体内移行を阻止するペプチド混合物と、このペプチド混合物を含有する組成物
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
JP4011638B2 (ja) * 1994-12-27 2007-11-21 イーエヌ大塚製薬株式会社 経口経腸栄養組成物
US5569680A (en) * 1995-02-13 1996-10-29 Trustees Of The Univ. Of Penna Method of treating inflammatory bowel disease with tributyrin
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
JPH09323979A (ja) * 1996-06-04 1997-12-16 Meiji Milk Prod Co Ltd 核酸を用いた免疫調節組成物
GB9701674D0 (en) * 1997-01-28 1997-03-19 Novartis Nutrition Ag Use of organic compounds
WO1998041216A1 (en) * 1997-03-17 1998-09-24 Tam Yun K Composition for prevention of hepatic steatosis
GB9709082D0 (en) * 1997-05-06 1997-06-25 Ciba Geigy Ag Organic compositions
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
AU2186699A (en) * 1998-02-09 1999-08-23 Meiji Milk Products Co., Ltd. Preventives and remedies for intestinal mucosal disorder
US6369252B1 (en) * 1998-02-26 2002-04-09 The University Of Georgia Research Foundation, Inc. Structured lipids
CA2343790A1 (en) * 1998-09-11 2000-03-23 Cultor Food Science, Inc. Reduced calorie plastic fat composition
JP2000119180A (ja) * 1998-10-06 2000-04-25 Nisshin Flour Milling Co Ltd 経腸栄養剤
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives

Also Published As

Publication number Publication date
RU2295952C2 (ru) 2007-03-27
CZ300129B6 (cs) 2009-02-18
EE200300198A (et) 2003-08-15
KR100861889B1 (ko) 2008-10-09
DE10057290B4 (de) 2004-01-08
CA2429270C (en) 2009-08-18
BRPI0115451B1 (pt) 2016-07-19
CA2429270A1 (en) 2002-05-23
SK286199B6 (sk) 2008-05-06
DE10057290A1 (de) 2002-06-06
JP2004513912A (ja) 2004-05-13
PT1337236E (pt) 2004-11-30
NO20032160L (no) 2003-07-14
HUP0301386A2 (hu) 2003-09-29
EP1337236A1 (de) 2003-08-27
IS6815A (is) 2003-05-14
PL361634A1 (en) 2004-10-04
AU2002224848B2 (en) 2006-06-15
HU228351B1 (hu) 2013-03-28
CN1477950A (zh) 2004-02-25
ATE272390T1 (de) 2004-08-15
CZ20031337A3 (cs) 2003-09-17
EP1337236B1 (de) 2004-08-04
KR20030069172A (ko) 2003-08-25
MXPA03004348A (es) 2003-08-19
IL155840A (en) 2008-11-03
EE05209B1 (et) 2009-10-15
SK5612003A3 (en) 2003-10-07
US7947303B2 (en) 2011-05-24
NZ525812A (en) 2004-03-26
WO2002039978A8 (de) 2002-07-18
IL155840A0 (en) 2003-12-23
SI1337236T1 (en) 2004-12-31
ZA200303722B (en) 2004-04-16
DE50103152D1 (de) 2004-09-09
KR20080069280A (ko) 2008-07-25
HRP20030395A2 (en) 2005-04-30
ES2223015T3 (es) 2005-02-16
DK1337236T3 (da) 2004-12-13
NO333003B1 (no) 2013-02-11
US20040097404A1 (en) 2004-05-20
IS2377B (is) 2008-07-15
WO2002039978A1 (de) 2002-05-23
AU2484802A (en) 2002-05-27
HRP20030395B1 (en) 2011-10-31
NO20032160D0 (no) 2003-05-13
HUP0301386A3 (en) 2008-04-28
PL202031B1 (pl) 2009-05-29

Similar Documents

Publication Publication Date Title
BR0115451A (pt) Suplemento a ser administrado por via enteral para a alimentação parenteral ou alimentação enteral/oral parcial em doentes crìticos, doentes crÈnicos e com nutrição deficiente
Zeisel Choline: an important nutrient in brain development, liver function and carcinogenesis.
EP0567216B1 (en) Composition comprising omega-3 fatty acid source and glutathione stimulator for the treatment of immunedisorders and viral infections
Badía-Tahull et al. A randomised study on the clinical progress of high-risk elective major gastrointestinal surgery patients treated with olive oil-based parenteral nutrition with or without a fish oil supplement
AU2007312216B2 (en) Long-term feed - cancer patient
TW201438719A (zh) 改善壓力症狀之母乳寡糖
RU2014121891A (ru) Улучшение узнавания
WO2015034812A2 (en) A new ketogenic diet and its use in treating the critically ill
JP2023100870A (ja) 対象におけるマイトファジーを改善するための方法
WO2009052106A2 (en) Formulation to improve gastrointestinal function
CN113615831B (zh) 一种促进溃疡性结肠炎粘膜修复的临床营养组合物及其制备方法
Huner et al. Breastfeeding experience in inborn errors of metabolism other than phenylketonuria
EP2880993A1 (en) Method of achieving memory and learning improvement by the administration of sialic acid
RU2010106275A (ru) Применение 5-метил-1,3-бенздиола или его производных в изготовлении лекарства и функционального продукта питания для лечения или предупреждения депрессии
Lilliu Treatment of organic acidurias and urea cycle disorders
Koletzko 3.4 Parenteral nutritional support
Appelboam et al. Nutrition in the critically ill patient
AU2020476040B2 (en) Parenteral nutrition formulation and methods of preparation thereof
Sindhav et al. Animal-based bioactive components: zoochemicals: a comprehensive review
WO2022096913A1 (en) Parenteral nutrition formulation and methods of preparation thereof
Gara-Rucińska et al. Nutritional problems in head and neck cancer patients
Sunavala 23 Approach to Nutritional Support
Cruse PEDIATRIC PARENTERAL NUTRITION
Sohrevardi et al. Enteral nutrition and phenytoin Administration in Head trauma patients
Quimby What is the optimal diet for chronic kidney disease?

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/07/2016, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2540 DE 10-09-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.